Skip to main content
Top
Published in: Diabetologia 2/2017

Open Access 01-02-2017 | Short Communication

Type 1 diabetes mellitus and risk of incident epilepsy: a population-based, open-cohort study

Authors: George E. Dafoulas, Konstantinos A. Toulis, Dougall Mccorry, Balachadran Kumarendran, G. Neil Thomas, Brian H. Willis, Krishna Gokhale, George Gkoutos, Parth Narendran, Krishnarajah Nirantharakumar

Published in: Diabetologia | Issue 2/2017

Login to get access

Abstract

Aims/Hypothesis

The aim of this research was to explore the relationship between incident epilepsy and type 1 diabetes in British participants.

Methods

Using The Health Improvement Network database, we conducted a retrospective, open-cohort study. Patients who were newly diagnosed with type 1 diabetes mellitus at the age of ≤40 years were identified and followed-up from 1 January 1990 to 15 September 2015. These patients, identified as not suffering from epilepsy at the time of diagnosis, were randomly matched with up to four individuals without type 1 diabetes mellitus, based on age, sex and participating general practice. A Cox regression analysis was subsequently performed using Townsend deprivation index, cerebral palsy, head injury and learning disabilities as model covariates.

Results

The study population consisted of a total of 24,610 individuals (4922 with type 1 diabetes and 19,688 controls). These individuals were followed up for a mean of 5.4 years (approximately 132,000 person-years of follow up). Patients with type 1 diabetes were significantly more likely to be diagnosed with epilepsy during the observation period compared with controls (crude HR [95% CI]: 3.02 [1.95, 4.69]). The incidence rate was estimated to be 132 and 44 per 100,000 person-years in patients and controls, respectively. This finding persisted after adjusting for model covariates (adjusted HR [95% CI]: 3.01 [1.93, 4.68]) and was also robust to sensitivity analysis, excluding adult-onset type 1 diabetes mellitus.

Conclusions/Interpretation

Patients with type 1 diabetes are at approximately three-times greater risk of developing epilepsy compared with matched controls without type 1 diabetes. This should be considered when investigating seizure-related disorders in patients with type 1 diabetes mellitus.
Literature
1.
2.
go back to reference Verrotti A, Scaparrotta A, Olivieri C, Chiarelli F (2012) Seizures and type 1 diabetes mellitus: current state of knowledge. Eur J Endocrinol 167:749–758 Verrotti A, Scaparrotta A, Olivieri C, Chiarelli F (2012) Seizures and type 1 diabetes mellitus: current state of knowledge. Eur J Endocrinol 167:749–758
3.
go back to reference Ramakrishnan R, Appleton R (2012) Study of prevalence of epilepsy in children with type 1 diabetes mellitus. Seizure 21:292–294CrossRefPubMed Ramakrishnan R, Appleton R (2012) Study of prevalence of epilepsy in children with type 1 diabetes mellitus. Seizure 21:292–294CrossRefPubMed
4.
go back to reference Chou IC, Wang CH, Lin WD, Tsai FJ, Lin CC, Kao CH (2016) Risk of epilepsy in type 1 diabetes mellitus: a population-based cohort study. Diabetologia 59:1196–1203CrossRefPubMed Chou IC, Wang CH, Lin WD, Tsai FJ, Lin CC, Kao CH (2016) Risk of epilepsy in type 1 diabetes mellitus: a population-based cohort study. Diabetologia 59:1196–1203CrossRefPubMed
5.
go back to reference McCorry D, Nicolson A, Smith D, Marson A, Feltbower RG, Chadwick DW (2006) An association between type 1 diabetes and idiopathic generalized epilepsy. Ann Neurol 59:204–206CrossRefPubMed McCorry D, Nicolson A, Smith D, Marson A, Feltbower RG, Chadwick DW (2006) An association between type 1 diabetes and idiopathic generalized epilepsy. Ann Neurol 59:204–206CrossRefPubMed
6.
go back to reference Mancardi MM, Striano P, Giannattasio A et al (2010) Type 1 diabetes and epilepsy: more than a casual association? Epilepsia 51:320–321CrossRefPubMed Mancardi MM, Striano P, Giannattasio A et al (2010) Type 1 diabetes and epilepsy: more than a casual association? Epilepsia 51:320–321CrossRefPubMed
7.
go back to reference Schober E, Otto KP, Dost A et al (2012) Association of epilepsy and type 1 diabetes mellitus in children and adolescents: is there an increased risk for diabetic ketoacidosis? J Pediatr 160:662–666CrossRefPubMed Schober E, Otto KP, Dost A et al (2012) Association of epilepsy and type 1 diabetes mellitus in children and adolescents: is there an increased risk for diabetic ketoacidosis? J Pediatr 160:662–666CrossRefPubMed
8.
go back to reference O’Connell MA, Harvey AS, Mackay MT, Cameron FJ (2008) Does epilepsy occur more frequently in children with type 1 diabetes? J Paediatr Child Health 44:586–589CrossRefPubMed O’Connell MA, Harvey AS, Mackay MT, Cameron FJ (2008) Does epilepsy occur more frequently in children with type 1 diabetes? J Paediatr Child Health 44:586–589CrossRefPubMed
9.
go back to reference Sander JW, Novy J, Keezer MR (2016) The intriguing relationship between epilepsy and type 1 diabetes mellitus. Diabetologia 59:1569–1570CrossRefPubMed Sander JW, Novy J, Keezer MR (2016) The intriguing relationship between epilepsy and type 1 diabetes mellitus. Diabetologia 59:1569–1570CrossRefPubMed
10.
go back to reference Meeraus WH, Petersen I, Chin RF, Knott F, Gilbert R (2013) Childhood epilepsy recorded in primary care in the UK. Arch Dis Child 98:195–202CrossRefPubMed Meeraus WH, Petersen I, Chin RF, Knott F, Gilbert R (2013) Childhood epilepsy recorded in primary care in the UK. Arch Dis Child 98:195–202CrossRefPubMed
11.
go back to reference Keezer MR, Novy J, Sander JW (2015) Type 1 diabetes mellitus in people with pharmacoresistant epilepsy: prevalence and clinical characteristics. Epilepsy Res 115:55–57CrossRefPubMed Keezer MR, Novy J, Sander JW (2015) Type 1 diabetes mellitus in people with pharmacoresistant epilepsy: prevalence and clinical characteristics. Epilepsy Res 115:55–57CrossRefPubMed
12.
go back to reference Kwan P, Sills GJ, Kelly K, Butler E, Brodie MJ (2000) Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study. Epilepsy Res 42:191–195CrossRefPubMed Kwan P, Sills GJ, Kelly K, Butler E, Brodie MJ (2000) Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study. Epilepsy Res 42:191–195CrossRefPubMed
13.
go back to reference Kirchner A, Veliskova J, Velisek L (2006) Differential effects of low glucose concentrations on seizures and epileptiform activity in vivo and in vitro. Eur J Neurosci 23:1512–1522CrossRefPubMed Kirchner A, Veliskova J, Velisek L (2006) Differential effects of low glucose concentrations on seizures and epileptiform activity in vivo and in vitro. Eur J Neurosci 23:1512–1522CrossRefPubMed
Metadata
Title
Type 1 diabetes mellitus and risk of incident epilepsy: a population-based, open-cohort study
Authors
George E. Dafoulas
Konstantinos A. Toulis
Dougall Mccorry
Balachadran Kumarendran
G. Neil Thomas
Brian H. Willis
Krishna Gokhale
George Gkoutos
Parth Narendran
Krishnarajah Nirantharakumar
Publication date
01-02-2017
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 2/2017
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-016-4142-x

Other articles of this Issue 2/2017

Diabetologia 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.